Sumitomo Pharma Co., Ltd. (DNPUF)

OTCMKTS · Delayed Price · Currency is USD
4.000
-0.599 (-13.02%)
At close: Apr 7, 2025
66.67%
Market Cap 1.98B
Revenue (ttm) 2.37B
Net Income (ttm) -1.12B
Shares Out n/a
EPS (ttm) -2.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 2,939
Open 4.000
Previous Close 4.599
Day's Range 4.000 - 4.000
52-Week Range 1.990 - 5.290
Beta 0.54
RSI 48.11
Earnings Date May 13, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical anti... [Read more]

Sector Healthcare
Founded 1897
Employees 4,980
Stock Exchange OTCMKTS
Ticker Symbol DNPUF
Full Company Profile

Financial Performance

In 2023, Sumitomo Pharma's revenue was 314.56 billion, a decrease of -43.38% compared to the previous year's 555.54 billion. Losses were -314.97 billion, 322.7% more than in 2022.

Financial numbers in JPY Financial Statements

News

There is no news available yet.